Today: 20 March 2026
Subscribe
Browse Category

LSE:HLN.L 6 January 2026 - 27 February 2026

Haleon PLC stock ticks up after earnings whiplash; here’s what matters for HLN shares

Haleon PLC stock ticks up after earnings whiplash; here’s what matters for HLN shares

Haleon shares rose 1% to 398.2 pence in early London trading Friday after sharp swings earlier in the week. The company reported 2025 revenue of £11.03 billion and forecast 3%-5% organic revenue growth for 2026, with a £500 million buyback planned. CEO Brian McNamara said U.S. growth is expected to return this year. Haleon’s next trading update is due April 29.
27 February 2026
··
Haleon share price rises in London as HLN stock turns to February results

Haleon share price rises in London as HLN stock turns to February results

Haleon shares rose 0.6% to 373.8 pence in early London trading Friday ahead of an anticipated update on its operating-model reset. Europe’s STOXX 600 index added 0.1% as investors awaited U.S. policy signals and corporate earnings. Haleon Pakistan this week announced a £3.58 million upgrade to its Panadol Liquid packaging line. Investors are seeking clarity on Haleon’s organic revenue growth and margin outlook.
30 January 2026
·

Stock Market Today

  • Kessler Topaz Meltzer & Check Files Securities Fraud Class Action Against Soleno Therapeutics
    March 20, 2026, 1:23 PM EDT. Kessler Topaz Meltzer & Check, LLP has filed a securities fraud class action lawsuit against Soleno Therapeutics, Inc. (NASDAQ: SLNO) concerning purchases of SLNO stock between March 26 and November 4, 2025. The lawsuit alleges that Soleno made materially false statements and omissions about safety concerns in its Phase 3 clinical trial for diazoxide choline extended-release tablets used to treat hyperphagia linked to Prader-Willi syndrome. The firm claims the company concealed issues relating to excess fluid retention in trial participants. Investors have until May 5, 2026, to seek lead plaintiff status. The complaint is pending in the U.S. District Court for the Northern District of California under case number 3:26-cv-01979. Investors who suffered losses are urged to contact the law firm for legal options at no cost.
Go toTop